Actively Recruiting
Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms
Led by Adnan Imtiaj Rahul · Updated on 2025-08-20
60
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to assess the effect of using baclofen along with conventional treatment in improving GERD symptoms. It will also assess the safety of drug baclofen by recording the patient reported adverse events. The main questions it aims to answer are : Does drug baclofen along with conventional treatment has any effect on patients with GERD symptoms? What medical problems do participants have when taking drug baclofen? Researcher will compare drug baclofen along with conventional treatment to a control group taking placebo along with conventional treatment. Participants will: Take drug baclofen 10 milligrams or placebo three times daily along with conventional treatment for 4 weeks. They will visit the hospital after 4 weeks. Their symptoms will be assessed via validated GERD Q questionnaire at baseline and after 4 weeks. Additionally, patient reported adverse events will be documented.
CONDITIONS
Official Title
Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 and above
- Patients with persistent GERD symptoms (heartburn and/or regurgitation) despite taking conventional treatment including PPI for 8 weeks
You will not qualify if you...
- GERD symptoms with any alarming features such as dysphagia, weight loss, bleeding, vomiting, or anemia
- Baseline GERD Q score less than 8
- Peptic gastric or duodenal ulcer found by endoscopy
- Other esophageal diseases like achalasia, carcinoma, or corrosive stricture
- Gastrointestinal malignancy
- History of major gastrointestinal surgery
- Medical diseases affecting esophageal or gastric motility such as uncontrolled diabetes, hyperthyroidism, or hypothyroidism
- Renal impairment
- Pregnant or lactating women
- Use of drugs affecting the lower esophageal sphincter
- Regular use of drugs that may interact with baclofen
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dhaka Medical College
Dhaka, Bangladesh
Actively Recruiting
Research Team
A
Adnan Imtiaj Rahul, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here